Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • EXPE vs GSK✓SelectedUSD · GSKEXPE vs GSK performance historyLatest closeAs of-3.77%11/17
Stock and ETF performance explorer

EXPE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+38.8%
GSK return
+43.9%
Excess return
-5.1%
Maximum drawdown
-60.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.8%-2.3%-1.5%-3.2%
7D-4.2%-3.0%-1.2%-3.5%
30D-15.8%+0.4%-16.2%-15.8%
3M-23.5%-1.2%-22.4%-23.2%
6M+12.1%+0.9%+11.1%+12.0%
YTD-13.7%+4.0%-17.7%-15.5%
1Y+0.3%+7.3%-7.0%-2.5%
3Y+80.8%+57.1%+23.7%+50.3%
5Y+38.8%+43.0%-4.1%-0.2%
All+38.8%+43.9%-5.1%-0.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling